THE INSULIN EFFECT ON THE PROLIFERATIVE ACTIVITY OF HUMAN BREAST AND PROSTATE CANCER CELLS VARYING IN MALIGNANCY DEGREES IN VITRO
DOI:
https://doi.org/10.32471/oncology.2663-7928.t-23-3-2021-g.9559Keywords:
breast cancer, cell lines, IPO-38, proliferative activity, prostate cancer, інсулін, Кі-67Abstract
Aim: to determine the effect of insulin on the proliferative activity of human breast and prostate cancer cells varying in malignancy degrees in an experimental system in vitro. Object and methods: the study was performed on human breast cancer (BC) T47D, MDA-MB-231, BCC/P and BC/ML and human prostate cancer (PC) LNCap, Du-145, PC-3 cell lines different in malignancy degree. Determination of the IPO-38 and Ki-67 nuclear antigens of proliferating cells expression was performed using an indirect variant of the immunofluorescence method. Results were examined Beckman Coulter DxFLEX fluorescence flow cytometer, followed by processing the results using the program CytExpert for DxFLEX. The effect of insulin on the proliferative activity of BC and PC cell lines was evaluated by the determining expression level of IPO-38 after 72 h of culturing cells with insulin at a concentration of 0.02 μg/ml (corresponds to its physiological concentration), and 0.5, 2 and 5 μg/ml (correspond the conditions of hyperinsulinemia). Results: It was found that insulin at the concentration 0.02 μg/ml stimulate the proliferative activity of low-grade BC cell lines T47D (luminal A subtype) and the androgen-sensitive PC cell line LNCap in 1.5 and 2.6 times respectively. At the same time, insulin’s physiological concentration did not influence on proliferative potential of high-grade BC cell lines — MDA-MB-231, BCC/P, BC/ML, and PC Du-145. Under conditions of hyperinsulinemia, the level of IPO-38 expression significantly increases in the low malignancy degree PC cell line LNCap, whereas in cells lines of high malignancy degree Du-145 and PC-3, the expression of IPO-38 did not differ significantly from those in the control. There was detected a decrease in luminal A subtype BC cell line T47D proliferative activity under hyperinsulinemia, while cells of the basal subtype tended to increase their proliferation only when cultured with insulin at a concentration of 5 μg/ml. Conclusions: proliferative activity of BC and PC cell lines under the action of insulin depends on their malignancy degree and the insulin concentration in the culture medium
References
Gupta ВВ. Mechanism of insulin action. Curr Science 1997; 73: 993–1003.
Wilcox G. Insulin and Insulin Resistance. Clin Biochem Rev 2005; 26 (2): 19–39.
Gerdes J, Schwab U, Lemke H, et al. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983; 31(1): 13–20.
Scholzen T, Gerdes J. The Ki-67 protein: from the known and the unknown. J Cell Physiol 2000; 182 (3): 311–22.
Menon SS, Guruvayoorappan C, Sakthivel KM, et al. Ki-67 protein as a tumour proliferation marker. Clin Chim Acta 2019; 491: 39–45.
Van der Kwast TH. Prognostic prostate tissue biomarkers of potential clinical use. Virchows Arch 2014; 464(3): 293–300.
Xie Y, Chen L, Ma X, et al. Prognostic and clinicopathological role of high Ki-67 expression in patients with renal cell carcinoma: a systematic review and meta-analysis. Sci Rep 2017; 7: 44281.
Tian Y, Ma Z, Chen Z, et al. Clinicopathological and prognostic value of Ki-67 Expression in bladder cancer: a systematic review and meta-analysis. PLoS One 2016; 11 (7): e0158891.
Yi ES, Lee GK. Updates on selected topics in lung cancers: air space invasion in adenocarcinoma and Ki-67 staining in carcinoid tumors. Arch Pathol Lab Med 2018; 142 (8): 947–951.
Chen YT, Tsai HP, Wu CC, et al. Нigh-level sp1 is associated with proliferation, invasion, and poor prognosis in astrocytoma. Pathol Oncol Res 2019; 25 (3): 1003–13.
Hartmann E, Ott G, Rosenwald A. Molecular outcome prediction in mantle cell lymphoma. Future Oncol 2009; 5 (1): 63–73.
Mikhalap SV, Lopes F, Shlapatskaya LN et al. Monoclonal antibody IPO-38 recognizes a novel nuclear antigen of proliferating cells. In: Leucocyte Typing VI. New York: Garland Publishing Inc. 1997: 609–610.
Mikhalap SV, Shlapatskaya LN, Berdova AG, et al. Monoclonal antibody IPO-38 in evaluation of proliferative activity of tumor cells. Exp Oncol 2000; 22 (2): 36–38.
Shlapatska LM, Zakharova IA, Mikhalap SV, et al. Expression of protein kinases D1 and D 2 in tumor cells of breast cancer. Oncology 2008; 10 (3): 316–21 (in Ukrainian).
Hao Y, Yu Y, Wang L, et al. IPO-38 is identified as a novel serum biomarker of gastric cancer based on clinical proteomics technology. J Proteome Res 2008; 7 (9): 3668–77.
Heuson JC, Legros N. Influence of insulin deprivation on growth of the 7,12-dimethylbenz(a)anthracene-induced mammary carcinoma in rats subjected to alloxan diabetes and food restriction. Cancer Res 1972; 32 (2): 226–32.
Nandi S, Guzman RC, Yang J. Hormones and mammary carcinogenesis in mice, rats, and humans: a unifying hypothesis. PNAS 1995; 92 (9): 3650
Zadvornyi TV, Lukianova NY, Borikun TV, et al. Effects of exogenous lactoferrin on phenotypic profile and invasiveness of human prostate cancer cells (DU-145 and LNCAP) in vitro. Exp Oncol 2018; 40 (3): 184–6.
Lukianova NY, Andriiv AV, Chekhun VF. Correlation of iodine symporter expression in highly and low malignant cell lines of human breast cancer differed in their sensitivity to doxorubicin. Exp Oncol 2016; 38 (3): 169–71.
Bezdieniezhnykh N, Lykhova A, Semesiuk N, et al. Establishment and characterization of new breast and ovarian cancer cell lines as a model for studying cellular plasticity in vitro. Exp Oncol 2016; 38 (2): 94–100.
